Forbes Medi-Tech (FMTI) to Sell Pharmaceutical Assets to Transition Therapeutics (TTHI)
More News related to FMTI
- Forbes Medi-Tech Announces Financial Results for Third Quarter Ended September 30, 2009
- Forbes Medi-Tech Announces Financial Results for Third Quarter Ended September 30, 2009
- Forbes Medi-Tech Cholesterol Lowering Ingredient Reducol(TM) Receives New Health Claim in the European Union
- Forbes Medi-Tech Cholesterol Lowering Ingredient Reducol(TM) Receives New Health Claim in the European Union
- Forbes Medi-Tech (FMTI) Sees No Reason For Stock Move
More News related to TTHI
- Transition Therapeutics Announces First Quarter Fiscal 2010 Financial Results
- Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2010 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST
- Transition Therapeutics (TTHI) $75 Million Mixed Securities Shelf
- Transition Therapeutics Files Shelf Registration Statement
- Transition Therapeutics Announces Fiscal 2009 Year End Financial Results
More News related to Mergers and Acquisitions
- HP (HPQ) Acquires 3Com (COMS) for $7.90 Per Share, or $2.7 Billion.
- HP (HPQ) buys 3Coms (COMS) for $7.90/Share Cash
- HP (HPQ) said to buy 3Com (COMS) for $2.7B
- Motorola (MOT) is going to seek buyers for its home and networks division, which is worth roughly $4.5 billion - WSJ
- Logitech (LOGI) Acquires LifeSize Comm for $405M
Forbes Medi-Tech Inc. (NASDAQ: FMTI) announced today the sale of its pharmaceutical assets and business unit based in San Diego, California to Transition Therapeutics Inc. (NASDAQ: TTHI).
Terms of the sale include an upfront payment of $1 million in cash paid at closing to Forbes along with potential future payments of up to $6 million, in cash or Transition shares, based upon Transition reaching certain developmental and regulatory milestones as outlined in the agreement.
Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of products for the prevention and treatment of life-threatening diseases.
Related Categories
Mergers and AcquisitionsStocks Mentioned
+0.00
-0.23Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
